共 50 条
Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
被引:23
|作者:
Kumarasamy, N.
[1
,3
]
Patel, Atul
[2
,3
]
Pujari, Sanjay
[3
,4
]
机构:
[1] YRG CARE Med Ctr, Voluntary Hlth Serv, Madras 600113, Tamil Nadu, India
[2] Vedant Inst Med Sci, Ahmadabad, Gujarat, India
[3] Inst Infect Dis, Pune, Maharashtra, India
[4] HIVMAI, Pune, Maharashtra, India
基金:
英国惠康基金;
关键词:
Antiretroviral drugs;
antiretroviral therapy;
ART;
CD4;
HIV;
IRIS;
viral load;
RECONSTITUTION INFLAMMATORY SYNDROME;
HIV-INFECTED PATIENTS;
CD4 CELL COUNTS;
COST-EFFECTIVENESS ANALYSIS;
ZIDOVUDINE-INDUCED ANEMIA;
LONG-TERM EFFICACY;
LINE VIRAL LOAD;
IMMUNE RECONSTITUTION;
RISK-FACTORS;
DRUG-RESISTANCE;
D O I:
10.4103/0971-5916.92626
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
With the rapid scale up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy - antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.
引用
收藏
页码:787 / 800
页数:14
相关论文